The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

Non-alcoholic fatty liver disease, now MASLD, is alarmingly prevalent among young, sedentary Indians. Studies reveal high ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the ...

The Tamil Nadu Health Department, in collaboration with Dr. MGR Medical University, has launched a study to assess the ...

Malnutrition can impact quality of life and survival of patients with liver disease. If you can improve malnutrition, you can ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

The Pharmaceutical Society of Ghana has issued a stark warning about the alarming rise in liver-related illnesses across the ...